Portfolio company
Acelyrin, Inc
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops protein therapeutics and monoclonal antibodies to treat inflammatory diseases for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bluefin Biomedicine
This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.
Odyssey Therapeutics
This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Edesa Biotech
This biopharmaceutical company develops monoclonal antibody treatments for patients suffering from acute and chronic inflammatory and immune-related diseases.
aTyr Pharma
The company develops protein-based immunomodulatory medicines for patients suffering from inflammatory lung diseases, such as pulmonary sarcoidosis, and various types of cancer.
Beeline Medicines
This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.
Arxx Therapeutics
This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.
Apogee Therapeutics
This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.
